MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression.
- DOI
- 10.1016/j.jcyt.2026.102931
- Published
- 2026 Jun 10
- Container
- Cytotherapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jcyt.2026.102931,
title = {MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression.},
author = {Gokcen S and Chu T and Blair PE and Krajewska NM and Brooke GN and Rushworth S and Laissue PP and Zwacka RM and Mohr A},
year = {2026},
journal = {Cytotherapy},
doi = {10.1016/j.jcyt.2026.102931},
url = {https://doi.org/10.1016/j.jcyt.2026.102931}
}RIS
TY - JOUR TI - MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression. AU - Gokcen S AU - Chu T AU - Blair PE AU - Krajewska NM AU - Brooke GN AU - Rushworth S AU - Laissue PP AU - Zwacka RM AU - Mohr A PY - 2026 JO - Cytotherapy DO - 10.1016/j.jcyt.2026.102931 UR - https://doi.org/10.1016/j.jcyt.2026.102931 ER -
APA
S, G., T, C., PE, B., NM, K., GN, B., S, R., PP, L., RM, Z., & A, M. (2026). MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression.. Cytotherapy. https://doi.org/10.1016/j.jcyt.2026.102931
Source records
- pubmed · retrieved 2026-09-26T14:58:33.040Z